Regal Investment Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Regal Investment Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-161,600	Closed	-$1.44M	–	308
2017 Q3	$1.44M	Sell	161,600 -20,003	-11%	-$206K	0.33%	99
2017 Q2	$2.3M	Sell	181,603 -22,542	-11%	-$267K	0.57%	59
2017 Q1	$2.15M	Sell	204,145 -24,728	-11%	-$263K	0.56%	66
2016 Q4	$2.11M	Buy	+228,873	New	+$2.59M	0.58%	65
2015 Q4	–	Sell	-180	Closed	-$5K	–	982
2015 Q3	$5K	Buy	+180	New	+$6.63K	﹤0.01%	818
2014 Q3	–	Sell	-360	Closed	-$6K	–	996
2014 Q2	$6K	Hold	360	–	–	﹤0.01%	753
2014 Q1	$7K	Hold	360	–	–	﹤0.01%	710
2013 Q4	$5K	Buy	+360	New	+$4.99K	﹤0.01%	685

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Regal Investment Advisors's INSY Position: Q4 2017 in Review

Regal Investment Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 161,600 shares — an estimated $1.44M sold.

Regal Investment Advisors first reported a position in INSY in Q4 2013 and held it in 8 quarters. The position peaked at $2.3M in Q2 2017. 112 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

Regal Investment Advisors reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Regal Investment Advisors sold 161,600 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $1.44M.
Regal Investment Advisors first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 8 quarters.
Regal Investment Advisors's Insys Therapeutics, Inc. position peaked at $2.3M in Q2 2017.
112 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Regal Investment Advisors's 13F filing for Q4 2017, filed 6 Feb 2018.